 |
|
|
 Cancer Please click on the following for further information: Medical need - Cancer, with increasing incidence, is the second..... Market situation - OncoporeTM - a potential blockbuster drug..... |
|
 September 01, 2010:
- Approval to start Phase IIa clinical trial with Lytixar™ (LTX-109)Oslo, Norway and Seoul, Korea, June 09, 2010:
- Lytix Biopharma and KAEL–GemVax announce approval of joint clinical trialMay 20, 2010:
- Update on the Phase I clinical trials of Oncopore™ (LTX-315) for the treatment of cancer.May 20, 2010:
- Approval by the Swedish Medical Products Agency to commence a Phase I/IIa clinical trial |
|||||
